参考文献/References:
[1]Ronco P,Debiec H.Membranous nephropathy:A fairy tale for immunopathologists,nephrologists and patients[J].Molecular Immunology,2015,68(1):57-62. [2]洪艳.特发性膜性肾病发病机制研究进展[J].实用医学杂志,2012,28(8):1379-1380. [3]Zhu P,Zhou F,Wang S,et al.Increasing frequency of idiopathic membranous nephropathy in primary glomerular disease:A 10-year renal biopsy study from a single Chinese nephrology centre[J].Nephrology,2015,20(8):560-566. [4]丁楠,郝丽,黎淮,等.原发性肾病综合征患者免疫指标变化的临床意义探讨[J].中国免疫学杂志,2011,27(4):356-359,381. [5]Xu X,Wang G,Chen N,et al Long-term exposure to air pollution and increased risk of membranous nephropathy in China[J].J Am SocNephrol,2016,27(12):3739-3746. [6]Hou JH,Zhu HX,Zhou ML,et al.Changes in the spectrum of kidney diseases:an analysis of 40,759 biopsy-proven cases from 2003 to 2014 in China[J].Kidney Dis (Basel),2018,4(1):10-19. [7]谢志勇,李志莲,董伟,等.慢性肾小球疾病谱演变和膜性肾病流行病学特点[J].临床肾脏病杂志,2019,19(7):471-476,492. [8]Tian C,Li L,Liu T,et al.Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy[J].International Urology and Nephrology,2019,51(8):1371-1377. [9]Pippin JW,Durvasula R,Petermann A,et al.DNA damage is a novel response to sublytic complement C5b-9–induced injury in podocytes[J].J ClinInvestig,2003,111(6):877-885. [10]Cheng GX,Liu JH,Gilbert A et al.Serum phospholipase A2 receptor antibodies and immunoglobulin G subtypes in adult idiopathic membranous nephropathy:Clinical value assessment[J].Clin Chim Acta,2019(490):135-141. [11]Zhang MF,Huang J,Zhang YM,et al.Complement activation products in the circulation and urine of primary membranous nephropathy[J].BMC Nephrol,2019(20):313. [12]Zhu H,Han Q,Zhang D,et al.The clinicopathological features of patients with membranous nephropathy.International Journal of Nephrology and Renovascular Disease[J].Volume,2018(11):33-40. [13]陈春红.IgG、C3和PLA2R在特发性膜性肾病患者中的特点[D].福建医科大学,2017. [14]Lin C,Zheng DX,Wang Y,et al.Clinical and pathological features of idiopathic membranous nephropathy in young people[J].Nephrology(Carlton),2019(24):599-604. [15]Zhang XD,Cui Z,Zhang MF,et al.Clinical implications of pathological features of primary membranous nephropathy[J].BMC Nephrol,2018(19):215. [16]刘冉冉,鄂静,郑亚莉.膜性肾病的临床及病理特点分析[J].宁夏医学杂志,2017,39(3):233-238. [17]Chen P,Shi SF,Qu Z,et al.Characteristics of patients with coexisting IgA nephropathy and membranous[J].Renal Failure,2018,40(1):213-218. [18]王波,刘志红,吴燕,等.特发性膜性肾病患者调节性T细胞和B淋巴细胞的变化及其临床意义[J].肾脏病与透析肾移植杂志, 2009, 18(4): 322-328. [19]姚磊,向阳,康铃.肾病综合征患者血清Ig和补体C3的测定及临床意义探讨[J].重庆医学,2006(18):1656-1657. [20]琚绍坦.肾病综合征患者血清免疫球蛋白及C3水平变化及临床意义[J].国际检验医学杂志,2017,38(6):854-855. [21]Tsai SF,Wu MJ,Chen CH.Low serum C3 level,high neutrophil-lymphocyte-ratio, and high platelet-lymphocyte-ratio all predicted poor long-term renal survivals in biopsy-confirmed idiopathic membranous nephropathy[J].Sci Rep,2019,9(1):6209. [22]Yamaguchi M,Ando M,Katsuno T,et al.Urinary protein and renal prognosis in idiopathic membranous nephropathy:a multicenter retrospective cohort study in Japan[J].Renal Failure,2018,40(1):435-441. [23]Dong J,Peng T,Gao J,et al.A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis[J].BMC Immunology,2018,19(1):18.
相似文献/References:
[1]何卫东,刘明春,陈秋月,等.育龄妇女风疹病毒化学发光法检测结果分析[J].医学信息,2018,31(16):145.[doi:10.3969/j.issn.1006-1959.2018.16.046]
HE Wei-dong,LIU Ming-chun,CHEN Qiu-yue,et al.Analysis of Detection Results of Rubella Virus by Chemiluminescence Method in Women of Childbearing Age[J].Medical Information,2018,31(19):145.[doi:10.3969/j.issn.1006-1959.2018.16.046]
[2]刘 枫.IgA肾病与系膜增生性肾炎临床特征的比较[J].医学信息,2019,32(16):95.[doi:10.3969/j.issn.1006-1959.2019.16.029]
LIU Feng.Comparison of Clinical Features between IgA Nephropathy and Mesangial Proliferative Nephritis[J].Medical Information,2019,32(19):95.[doi:10.3969/j.issn.1006-1959.2019.16.029]